Chitolytic

ChitoLytic is a biotechnology company that manufactures and supplies high-purity, high-quality chitosan derived from crustacean shells and non-animal, vegetal sources. The company utilizes proprietary clean-tech enzymatic processes and patented non-thermal atmospheric pressure nitrogen plasma technology to decontaminate its chitosan. This plasma-treatment innovation is critical, as it eliminates impurities, pyrogens, and endotoxins without the damaging effects of traditional sterilization methods like harsh chemicals or irradiation, enabling the material to meet the rigorous standards required for advanced biomedical, pharmaceutical, and medical device applications.

By providing medical-grade, sterile, and endotoxin-free chitosan, ChitoLytic enables researchers and manufacturers to leverage the biopolymer's natural properties—such as biocompatibility, antimicrobial activity, and hemostatic capabilities—in sensitive areas including drug delivery vehicles, tissue engineering scaffolds, and implantable medical devices. Beyond high-end biomedical use, the company supports a broad spectrum of sectors, offering mid-grade and industrial-grade chitosan for applications in nutraceuticals, cosmetics, agriculture, food preservation, and water treatment. The company, which originated from research collaborations at Memorial University, serves a global customer base from its headquarters in Toronto, Canada.